1. Home
  2. CODX vs GXAI Comparison

CODX vs GXAI Comparison

Compare CODX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • GXAI
  • Stock Information
  • Founded
  • CODX 2013
  • GXAI 2021
  • Country
  • CODX United States
  • GXAI United States
  • Employees
  • CODX N/A
  • GXAI N/A
  • Industry
  • CODX Medical/Dental Instruments
  • GXAI
  • Sector
  • CODX Health Care
  • GXAI
  • Exchange
  • CODX Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • CODX 9.8M
  • GXAI 9.7M
  • IPO Year
  • CODX 2017
  • GXAI 2023
  • Fundamental
  • Price
  • CODX $0.28
  • GXAI $1.25
  • Analyst Decision
  • CODX Buy
  • GXAI
  • Analyst Count
  • CODX 2
  • GXAI 0
  • Target Price
  • CODX $5.50
  • GXAI N/A
  • AVG Volume (30 Days)
  • CODX 1.1M
  • GXAI 153.1K
  • Earning Date
  • CODX 08-07-2025
  • GXAI 08-12-2025
  • Dividend Yield
  • CODX N/A
  • GXAI N/A
  • EPS Growth
  • CODX N/A
  • GXAI N/A
  • EPS
  • CODX N/A
  • GXAI N/A
  • Revenue
  • CODX $3,497,583.00
  • GXAI $27,740.00
  • Revenue This Year
  • CODX N/A
  • GXAI N/A
  • Revenue Next Year
  • CODX $42.11
  • GXAI N/A
  • P/E Ratio
  • CODX N/A
  • GXAI N/A
  • Revenue Growth
  • CODX N/A
  • GXAI 9987.27
  • 52 Week Low
  • CODX $0.23
  • GXAI $1.00
  • 52 Week High
  • CODX $2.23
  • GXAI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • CODX 51.71
  • GXAI 50.41
  • Support Level
  • CODX $0.26
  • GXAI $1.19
  • Resistance Level
  • CODX $0.29
  • GXAI $1.65
  • Average True Range (ATR)
  • CODX 0.02
  • GXAI 0.09
  • MACD
  • CODX 0.00
  • GXAI -0.01
  • Stochastic Oscillator
  • CODX 64.83
  • GXAI 30.50

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: